{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:30:58Z","timestamp":1776954658403,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.atherosclerosis.2017.02.014","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T07:31:21Z","timestamp":1487662281000},"page":"99-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Simvastatin treatment aggravates the glucocorticoid insufficiency associated with hypocholesterolemia in mice"],"prefix":"10.1016","volume":"261","author":[{"given":"Amber B.","family":"Ouweneel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3435-8356","authenticated-orcid":false,"given":"Ronald J.","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joya E.","family":"Nahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Van Eck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menno","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000362736","article-title":"Stress, the stress system and the role of glucocorticoids","volume":"22","author":"Nicolaides","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib2","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib3","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1172\/JCI118716","article-title":"Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production","volume":"97","author":"Plump","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0021-9258(17)40617-X","article-title":"Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat","volume":"252","author":"Balasubramaniam","year":"1977","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1194\/jlr.M030080","article-title":"LCAT deficiency in mice is associated with a diminished adrenal glucocorticoid function","volume":"54","author":"Hoekstra","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib6","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/ATVBAHA.112.300784","article-title":"Adrenal-specific scavenger receptor BI deficiency induces glucocorticoid insufficiency and lowers plasma very-low-density and low-density lipoprotein levels in mice","volume":"33","author":"Hoekstra","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib8","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1194\/jlr.P033449","article-title":"High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C","volume":"54","author":"Bochem","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00134-003-2021-7","article-title":"HDL-cholesterol level and cortisol response to synacthen in critically ill patients","volume":"29","author":"van der Voort","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1194\/jlr.M066019","article-title":"HDL is redundant for adrenal steroidogenesis in LDLR knockout mice with a human-like lipoprotein profile","volume":"57","author":"Hoekstra","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-54-1-27","article-title":"Adrenal function in heterozygous and homozygous hypobetalipoproteinemia","volume":"54","author":"Illingworth","year":"1982","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib12","first-page":"115","article-title":"Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH","volume":"100","author":"Illingworth","year":"1982","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/jcem-50-5-977","article-title":"Impaired cortisol secretion in abetalipoproteinemia","volume":"50","author":"Illingworth","year":"1980","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.CIR.55.5.767","article-title":"HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study","volume":"55","author":"Castelli","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2000.7716a","article-title":"Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia","volume":"49","author":"Dobs","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1055\/s-2007-1011900","article-title":"Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin)","volume":"19","author":"Fojo","year":"1987","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib18","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1073\/pnas.82.18.6291","article-title":"The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia","volume":"82","author":"Illingworth","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2125.1991.tb03924.x","article-title":"Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia","volume":"32","author":"Jay","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jcem-72-3-567","article-title":"The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia","volume":"72","author":"Prihoda","year":"1991","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000182114","article-title":"Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, pravastatin, on corticosteroid metabolism in patients with heterozygous familial hypercholesterolemia","volume":"36","author":"Takeda","year":"1991","journal-title":"Horm. Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib22","first-page":"836","article-title":"Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads","volume":"80","author":"Travia","year":"1995","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2015.10.021","article-title":"A\u00a0phase 3 study of evolocumab (AMG 145) in statin-treated Japanese patients at high cardiovascular risk","volume":"117","author":"Kiyosue","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1185\/030079907X210507","article-title":"Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy","volume":"23","author":"Mikhailidis","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.105.094136","article-title":"Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin","volume":"316","author":"Thelen","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-15-0023","article-title":"Adrenocortical LDL receptor function negatively influences glucocorticoid output","volume":"226","author":"van der Sluis","year":"2015","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib27","doi-asserted-by":"crossref","first-page":"25448","DOI":"10.1074\/jbc.M301189200","article-title":"Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells","volume":"278","author":"Hoekstra","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0005-2760(90)90139-O","article-title":"Tissue-selective inhibition of cholesterol synthesis in\u00a0vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"1045","author":"Koga","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1194\/jlr.M067488","article-title":"Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice","volume":"57","author":"Schonewille","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","article-title":"Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER)","volume":"105","author":"Nicholls","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1194\/jlr.M700475-JLR200","article-title":"Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting","volume":"49","author":"Hoekstra","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1194\/jlr.M800410-JLR200","article-title":"Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production","volume":"50","author":"Hoekstra","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib33","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00431.2010","article-title":"Plasma lipoproteins are required for both basal and stress-induced adrenal glucocorticoid synthesis and protection against endotoxemia in mice","volume":"299","author":"Hoekstra","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.02.014_bib34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/eci.12304","article-title":"Most appropriate animal models to study the efficacy of statins: a systematic review","volume":"44","author":"Pecoraro","year":"2014","journal-title":"Eur. J. Clin. Invest."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T13:34:54Z","timestamp":1658669694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017300667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"alternative-id":["S0021915017300667"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.02.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin treatment aggravates the glucocorticoid insufficiency associated with hypocholesterolemia in mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}